| Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight. Lolli G., Cozza G., Mazzorana M., Tibaldi E., Cesaro L., Donella-Deana A., Meggio F., Venerando A., Franchin C., Sarno S. et al.
Biochemistry 51:6097-6107(2012) · Mapped (1) |
| Structural determinants of protein kinase CK2 regulation by autoinhibitory polymerization. Lolli G., Pinna L.A., Battistutta R.
ACS Chem. Biol. 7:1158-1163(2012) · Mapped (2) |
| Structural and functional analysis of the flexible regions of the catalytic alpha-subunit of protein kinase CK2. Papinutto E., Ranchio A., Lolli G., Pinna L.A., Battistutta R.
J. Struct. Biol. 177:382-391(2012) · Mapped (5) |
| Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer. Battistutta R., Cozza G., Pierre F., Papinutto E., Lolli G., Sarno S., O'Brien S.E., Siddiqui-Jain A., Haddach M., Anderes K. et al.
Biochemistry 50:8478-8488(2011) · Mapped (1) |
| Binding to DNA of the RNA-polymerase II C-terminal domain allows discrimination between Cdk7 and Cdk9 phosphorylation. Lolli G.
Nucleic Acids Res. 37:1260-1268(2009) · UniProtKB (2) |
| The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. Baumli S., Lolli G., Lowe E.D., Troiani S., Rusconi L., Bullock A.N., Debreczeni J.E., Knapp S., Johnson L.N.
EMBO J. 27:1907-1918(2008) · UniProtKB (1) · Mapped (7) |
| Recognition of Cdk2 by Cdk7. Lolli G., Johnson L.N.
Proteins 67:1048-1059(2007) · UniProtKB (2) |
| CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs? Lolli G., Johnson L.N.
Cell Cycle 4:572-577(2005) · UniProtKB (1) |
| The crystal structure of human CDK7 and its protein recognition properties. Lolli G., Lowe E.D., Brown N.R., Johnson L.N.
Structure 12:2067-2079(2004) · UniProtKB (1) · Mapped (1) |
